SCHEMBL7220906

SCHEMBL7220906

Clc1cc(-c2ccccc2)on1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 8/20 0.61
NPC1 O15118 8/20 0.61
ALDH1A1 P00352 3/20 0.55
NOTUM Q6P988 1/20 0.53
SMN1; SMN2 Q16637 3/20 0.52
TDP1 Q9NUW8 2/20 0.52
L3MBTL1 Q9Y468 2/20 0.52
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
HPGD P15428 2/20 0.50
CASP3 P42574 1/20 0.50
SENP8 Q96LD8 1/20 0.50
SENP7 Q9BQF6 1/20 0.50
SENP6 Q9GZR1 1/20 0.50
MAPT P10636 1/20 0.50
PKM P14618 1/20 0.50
PTGS2 P35354 2/20 0.44
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
3,5-Diphenylisoxazole SCHEMBL1421260 0.76 NPC1 (1.00) RAB9ANPC1ALDH1A1NOTUMSMN1; SMN2
SCHEMBL23221303 0.75 RAB9A (0.57) RAB9ANPC1ALDH1A1NOTUMSMN1; SMN2
SCHEMBL28670403 0.75 RAB9A (1.00) RAB9ANPC1SMN1; SMN2TDP1L3MBTL1
SCHEMBL10341983 0.74 RAB9A (0.67) RAB9ANPC1ALDH1A1NOTUMSMN1; SMN2
SCHEMBL8258186 0.74 NPC1 (0.96) RAB9ANPC1ALDH1A1NOTUMSMN1; SMN2
SCHEMBL3081196 0.74 RAB9A (0.61) RAB9ANPC1ALDH1A1NOTUMSMN1; SMN2
SCHEMBL5157687 0.74 RAB9A (0.61) RAB9ANPC1ALDH1A1NOTUMSMN1; SMN2
SCHEMBL1013006 0.74 RAB9A (0.61) RAB9ANPC1ALDH1A1NOTUMSMN1; SMN2
SCHEMBL354607 0.74 RAB9A (0.61) RAB9ANPC1ALDH1A1NOTUMSMN1; SMN2
SCHEMBL27903378 0.74 RAB9A (0.61) RAB9ANPC1ALDH1A1NOTUMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6544982-B1 3-aryl-5-aminoisoxazole derivatives MERCK & CO., INC. 2003-04-08 US disclosed
US-6005116-A HAVE INHIBITION ACTIVITIES AGAINST TYPE A-MONOAMINE OXIDASE; TREATING OR PREVENTING DEPRESSION, PARKINSON'S DISEASE, ALZEHEIMER'S DEMENTIA, OR CEREBROVASCULAR DEMENTIA SANKYO COMPANY, LIMITED (JP) 1999-12-21 US disclosed
CN-1216986-A Isoxazole derivatives SANKYO CO (JP) 1999-05-19 CN disclosed
CN-1042225-C Piperidyloxy-and quinuclidinyloxy-isoxazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-02-24 CN disclosed
EP-0885891-A1 ISOXAZOLE DERIVATIVES SANKYO COMPANY LIMITED (JP) 1998-12-23 EP disclosed
EP-0456519-B1 Piperidyloxy- and quinuclidinyloxy- isoxazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1994-07-13 EP disclosed
CN-1057259-A Piperidines oxygen base and quinine epoxy group(ing) different  oxazole derivatives, their preparation and the application aspect treatment thereof SANKYO CO (JP) 1991-12-25 CN disclosed
EP-0456519-A1 Piperidyloxy- and quinuclidinyloxy- isoxazole derivatives, their preparation and their therapeutic use Sankyo Company Limited (JP) 1991-11-13 EP disclosed
US-4005202-A 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity SYNTEX (U.S.A.) INC. (US) 1977-01-25 US disclosed
US-3935209-A 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity SYNTEX (U.S.A.) INC. (US) 1976-01-27 US disclosed